4 found
Order:
  1.  17
    Cost-Effectiveness Analysis of Triple Test in Second-Trimester Maternal Serum Screening for Down’s Syndrome: An Experience From Taiwan with Decreasing Birth Rate but Increasing Population of Old Pregnant Women.Hsiao-Lin Hwa, Ming-Fang Yen, Chen-Li Lin, Tsang-Ming Ko, Fon-Jou Hsieh & Tony Hsiu-Hsi Chen - 2008 - Journal of Evaluation in Clinical Practice 14 (2):191-197.
  2.  17
    First‐Trimester Down Syndrome Screening in Women Younger Than 35 Years Old and Cost‐Effectiveness Analysis in Taiwan Population.Ching-Yu Chou, Fon-Jou Hsieh, Mei-Leng Cheong, Fa-Kung Lee, Bo-Quing She & Ming-Song Tsai - 2009 - Journal of Evaluation in Clinical Practice 15 (5):789-796.
  3.  22
    Risk Prediction for Down's Syndrome in Young Pregnant Women Using Maternal Serum Biomarkers: Determination of Cut‐Off Risk From Receiver Operating Characteristic Curve Analysis.Hsiao-Lin Hwa, Tsang-Ming Ko, Fon-Jou Hsieh, Ming-Fang Yen, Kai-Pei Chou & Tony Hsiu-Hsi Chen - 2007 - Journal of Evaluation in Clinical Practice 13 (2):254-258.
  4.  12
    Prediction of Breast Cancer and Lymph Node Metastatic Status with Tumour Markers Using Logistic Regression Models.Hsiao-Lin Hwa, Wen-Hong Kuo, Li-Yun Chang, Ming-Yang Wang, Tao-Hsin Tung, King-Jen Chang & Fon-Jou Hsieh - 2008 - Journal of Evaluation in Clinical Practice 14 (2):275-280.